CA2142996C - Breast implant with radiolucent shell - Google Patents
Breast implant with radiolucent shell Download PDFInfo
- Publication number
- CA2142996C CA2142996C CA002142996A CA2142996A CA2142996C CA 2142996 C CA2142996 C CA 2142996C CA 002142996 A CA002142996 A CA 002142996A CA 2142996 A CA2142996 A CA 2142996A CA 2142996 C CA2142996 C CA 2142996C
- Authority
- CA
- Canada
- Prior art keywords
- shell
- breast implant
- radiolucent
- urethane
- breast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/12—Mammary prostheses and implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Prostheses (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Abstract
A breast implant includes a shell fashioned from one of a group of materials which exhibit radiolucency at those x-ray in-tensities normally encountered for mammographic procedures. The radiolucent shell may be filled with radiolucent fill material as previously taught to thereby comprise a fully radiolucent breast implant.
The radiolucent breast implant enhances the use of mammography in detecting tumors in patients having breast implants to more effectively diagnose and treat cancer.
The radiolucent breast implant enhances the use of mammography in detecting tumors in patients having breast implants to more effectively diagnose and treat cancer.
Description
,. > ..
BREAST IMPLANT WITH RADIOLUCENT SHELL
Background and Summary of the Invention Breast prostheses are well known in the art and generally include a shell or envelope which is filled with a fluid or gel which desirably is used to enlarge the female breast yet retain its normal appearance, move-ment, feel, and other cosmetic characteristics. Until recently, the predominant breast implant had been a sili-cone envelope filled with a silicone gel. However, re-cent health concerns have prompted the withdrawal of this implant from the market. These concerns generally relate to the health risks caused by migration of the silicone gel from within the shell, breakage of the shell, or other introduction of the silicone gel into the~body.
The assignee of the present invention also holds certain rights under U.S. Patent No. 4,995,882, which discloses and claims a breast implant comprised of a silicone shell filled with a radiolucent fill material such as peanut oil, sunflower seed oil, or any other suitable fluid with the same atomic number as breast tissue, Z=5.9. As explained in greater detail therein, ' ' PCT/US93/07384 WO 94/0743 : ~ ~ - _ ,' mammograms typically are performed by compressing a breast between two plates which flattens the breast and enables a more uniform exposure. A controlled intensity of x-rays are then passed through the breast for a care-fully controlled time period to image any artifacts in-dicative of cancer. As is well known in the art of mam-mography, great care is taken to minimize the amount of x-ray energy used as studies have shown that certain levels of x-ray exposure will itself increase the risk of developing cancer. Typically, mammographies are conduct-ed at low x-ray energy levels, such as between the range of 25-60 kVp. Hence, this prior patent discloses a use-ful and valuable invention of utilizing a fill material which is radiolucent using standard mammographic proce-dures and protocols, and perhaps more importantly, x-ray intensities.
The inventors herein are also aware of U.S. Patent No. 4,863,470 which discloses a standard breast implant comprised of a silicone shell with a silicone gel fill material. As previously mentioned herein, this breast implant construction is well known in the prior art and, up until recently, had been the most popular implant used. in addition, this patent discloses an identifica-tion marker or tab which is made from silicone with bis-muth trioxide or barium sulfate, both of which are much more "radiopaque°' than the silicone used for the standard shell or fill material. Hence, presuming an increased x-ray intensity which would render the standard silicone breast implant radiolucent, a marker or tab would remain opaque and thusly visible. This patent also describes a technique used to read this radiopaque marker which is more similar to a chest x-ray than to a mammogram. As taught therein, the patient lies on her back and the x- , rays are directed through her breast and chest cavity.
For chest x-rays, energy levels at 125 kVp are common.
The intensity of x-rays required for this procedure sub-x WO 94/07434 ~ ' ' ~ ~ PCT/US93/07384 stantially exceeds that carefully controlled and timed dosage which is used for mammographic procedures. There-fore, while this patent suggests that a standard silicone gel and silicone fill material may be radiolucent, it is in reality radiopaque for standard mammographic proce-dures. This deficiency with this prior art implant con-struction was recognized and dramatically improved upon with the breast implant with radiolucent fill disclosed and claimed in prior U.S. Patent 4,995,882.
As an enhancement to the breast implant with silicone shell and radiolucent fill, the inventors herein have succeeded in developing a breast implant With a shell which is also radiolucent. Therefore, with this breast implant, not only is the fill material comprised of a radiolucent material, but the shell also is radiolu-cent itself, using the standards for fudging radiolucency as explained in prior U.S. Patent 4,995,882, i.e. using standard mammographic protocols, procedures, and intensi-ties. The material which the inventors have identified and are contemplating for use for the shell include any ,, one or more of the following: linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether urethane; aromatic polyester urethane; polybutylene; polypropylene; crosslinked ole-finic elastomers; and styrene-ethylene/butylene-styrene block copolymer. All of these materials have an effec-tive atomic number of 6.0 within a range of 0.5, and therefore exhibit the effective atomic number of fat which is the mayor component of a human breast. Thus, with the present invention, a breast implant is disclosed which includes a radiolucent shell filled with a radiolu-cent fill material thereby rendering the entire implant optimally radiolucent for mammographic procedures.
BREAST IMPLANT WITH RADIOLUCENT SHELL
Background and Summary of the Invention Breast prostheses are well known in the art and generally include a shell or envelope which is filled with a fluid or gel which desirably is used to enlarge the female breast yet retain its normal appearance, move-ment, feel, and other cosmetic characteristics. Until recently, the predominant breast implant had been a sili-cone envelope filled with a silicone gel. However, re-cent health concerns have prompted the withdrawal of this implant from the market. These concerns generally relate to the health risks caused by migration of the silicone gel from within the shell, breakage of the shell, or other introduction of the silicone gel into the~body.
The assignee of the present invention also holds certain rights under U.S. Patent No. 4,995,882, which discloses and claims a breast implant comprised of a silicone shell filled with a radiolucent fill material such as peanut oil, sunflower seed oil, or any other suitable fluid with the same atomic number as breast tissue, Z=5.9. As explained in greater detail therein, ' ' PCT/US93/07384 WO 94/0743 : ~ ~ - _ ,' mammograms typically are performed by compressing a breast between two plates which flattens the breast and enables a more uniform exposure. A controlled intensity of x-rays are then passed through the breast for a care-fully controlled time period to image any artifacts in-dicative of cancer. As is well known in the art of mam-mography, great care is taken to minimize the amount of x-ray energy used as studies have shown that certain levels of x-ray exposure will itself increase the risk of developing cancer. Typically, mammographies are conduct-ed at low x-ray energy levels, such as between the range of 25-60 kVp. Hence, this prior patent discloses a use-ful and valuable invention of utilizing a fill material which is radiolucent using standard mammographic proce-dures and protocols, and perhaps more importantly, x-ray intensities.
The inventors herein are also aware of U.S. Patent No. 4,863,470 which discloses a standard breast implant comprised of a silicone shell with a silicone gel fill material. As previously mentioned herein, this breast implant construction is well known in the prior art and, up until recently, had been the most popular implant used. in addition, this patent discloses an identifica-tion marker or tab which is made from silicone with bis-muth trioxide or barium sulfate, both of which are much more "radiopaque°' than the silicone used for the standard shell or fill material. Hence, presuming an increased x-ray intensity which would render the standard silicone breast implant radiolucent, a marker or tab would remain opaque and thusly visible. This patent also describes a technique used to read this radiopaque marker which is more similar to a chest x-ray than to a mammogram. As taught therein, the patient lies on her back and the x- , rays are directed through her breast and chest cavity.
For chest x-rays, energy levels at 125 kVp are common.
The intensity of x-rays required for this procedure sub-x WO 94/07434 ~ ' ' ~ ~ PCT/US93/07384 stantially exceeds that carefully controlled and timed dosage which is used for mammographic procedures. There-fore, while this patent suggests that a standard silicone gel and silicone fill material may be radiolucent, it is in reality radiopaque for standard mammographic proce-dures. This deficiency with this prior art implant con-struction was recognized and dramatically improved upon with the breast implant with radiolucent fill disclosed and claimed in prior U.S. Patent 4,995,882.
As an enhancement to the breast implant with silicone shell and radiolucent fill, the inventors herein have succeeded in developing a breast implant With a shell which is also radiolucent. Therefore, with this breast implant, not only is the fill material comprised of a radiolucent material, but the shell also is radiolu-cent itself, using the standards for fudging radiolucency as explained in prior U.S. Patent 4,995,882, i.e. using standard mammographic protocols, procedures, and intensi-ties. The material which the inventors have identified and are contemplating for use for the shell include any ,, one or more of the following: linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether urethane; aromatic polyester urethane; polybutylene; polypropylene; crosslinked ole-finic elastomers; and styrene-ethylene/butylene-styrene block copolymer. All of these materials have an effec-tive atomic number of 6.0 within a range of 0.5, and therefore exhibit the effective atomic number of fat which is the mayor component of a human breast. Thus, with the present invention, a breast implant is disclosed which includes a radiolucent shell filled with a radiolu-cent fill material thereby rendering the entire implant optimally radiolucent for mammographic procedures.
4 ~ ~ ~ ~ ~ ~ ~ PCT/US93/07384 4' It is not believed that a drawing is required or even helpful in understanding the present invention and, hence, none is being submitted.
Detailed Description of the Preferred Embodiment ' The inventors' preferred embodiment for achieving a breast implant shell which is essentially radiolucent using standard mammographic procedures, protocols, and intensities. The inventors believe that materials having an effective atomic number of 6.0 within a range of t0.5 satisfy this criteria. As examples thereof, the present invention includes fashioning the shell from any one of a number of materials such as: linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether urethane; aromatic polyester urethane; polybutylene; polypropylene; crosslinked ole-finic elastomers; and styrene-ethylene/butylene-styrene block copolymer. It is anticipated that standard manu-facturing techniques well known to those of ordinary skill in the art for producing breast implants will be similarly used with the materials of the present inven-tion. In other words, it is not anticipated that there will be any difficulty encountered by those of ordinary skill in the art in making breast implant shells with the materials suggested herein as radiolucent.
There are various changes and modifications which may be made to the invention as would be apparent to those skilled in the art. However, these changes or modifications are included in the teaching of the disclo-sure, and it is intended that the invention be limited only by the scope of the claims appended hereto.
Detailed Description of the Preferred Embodiment ' The inventors' preferred embodiment for achieving a breast implant shell which is essentially radiolucent using standard mammographic procedures, protocols, and intensities. The inventors believe that materials having an effective atomic number of 6.0 within a range of t0.5 satisfy this criteria. As examples thereof, the present invention includes fashioning the shell from any one of a number of materials such as: linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether urethane; aromatic polyester urethane; polybutylene; polypropylene; crosslinked ole-finic elastomers; and styrene-ethylene/butylene-styrene block copolymer. It is anticipated that standard manu-facturing techniques well known to those of ordinary skill in the art for producing breast implants will be similarly used with the materials of the present inven-tion. In other words, it is not anticipated that there will be any difficulty encountered by those of ordinary skill in the art in making breast implant shells with the materials suggested herein as radiolucent.
There are various changes and modifications which may be made to the invention as would be apparent to those skilled in the art. However, these changes or modifications are included in the teaching of the disclo-sure, and it is intended that the invention be limited only by the scope of the claims appended hereto.
Claims (5)
1. A breast implant comprised of a shell filled with a filler, both said shell and filler being each made of materials which are themselves substantially radiolu-cent under accepted mammographic protocols and intensi-ties.
2. The implant of Claim 1 wherein said shell is a material selected from the group consisting of linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether urethane; aromatic polyester urethane; polybutylene;
polypropylene; crosslinked olefinic elastomers; and sty-rene-ethylene/butylene-styrene block copolymer.
polypropylene; crosslinked olefinic elastomers; and sty-rene-ethylene/butylene-styrene block copolymer.
3. In a breast implant comprised of a shell filled with a fill material, the improvement comprising said shell being made of a material which is itself substan-tially radiolucent under accepted mammographic protocols and intensities.
4. The breast implant of Claim 3 wherein said shell is a material selected from the group consisting of linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether ure-thane; aromatic polyester urethane: polybutylene; poly-propylene; crosslinked olefinic elastomers; and styrene-ethylene/butylene-styrene block copolymer.
5. A breast implant comprised of a shell filled with a filler, both said shell and filler being made of materials having an effective atomic number of 6.0 within a range of about ~0.5.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95268792A | 1992-09-29 | 1992-09-29 | |
| US07/952,687 | 1992-09-29 | ||
| PCT/US1993/007384 WO1994007434A1 (en) | 1992-09-29 | 1993-08-06 | Breast implant with radiolucent shell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2142996A1 CA2142996A1 (en) | 1994-04-14 |
| CA2142996C true CA2142996C (en) | 2004-03-02 |
Family
ID=25493141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002142996A Expired - Lifetime CA2142996C (en) | 1992-09-29 | 1993-08-06 | Breast implant with radiolucent shell |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0693910A1 (en) |
| JP (1) | JPH09506516A (en) |
| AU (1) | AU683223B2 (en) |
| BR (1) | BR9307139A (en) |
| CA (1) | CA2142996C (en) |
| WO (1) | WO1994007434A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6290723B1 (en) | 1994-06-14 | 2001-09-18 | Winston A. Andrews | Method of making a synthetic triglyceride filler material |
| US5941909A (en) * | 1995-02-14 | 1999-08-24 | Mentor Corporation | Filling material for soft tissue implant prostheses and implants made therewith |
| US5658329A (en) * | 1995-02-14 | 1997-08-19 | Mentor Corporation | Filling material for soft tissue implant prostheses and implants made therewith |
| US5824081A (en) * | 1996-09-13 | 1998-10-20 | Lipomatrix Incorporated | Hydraulic foam tissue implant |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5141581A (en) * | 1972-10-08 | 1992-08-25 | Markham Harold A | Implants with a cover which resists formation of firm spherical encapsulation |
| US4157085A (en) * | 1978-03-24 | 1979-06-05 | Dow Corning Corporation | Surgically implantable tissue expanding device and the method of its use |
| US4995882A (en) * | 1989-08-28 | 1991-02-26 | Washington University | Radiolucent breast implant |
| FR2675049A1 (en) * | 1991-04-09 | 1992-10-16 | Mas Jean Claude | Implantable mammary prosthesis |
-
1993
- 1993-08-06 WO PCT/US1993/007384 patent/WO1994007434A1/en not_active Application Discontinuation
- 1993-08-06 CA CA002142996A patent/CA2142996C/en not_active Expired - Lifetime
- 1993-08-06 AU AU49983/93A patent/AU683223B2/en not_active Ceased
- 1993-08-06 JP JP6509011A patent/JPH09506516A/en active Pending
- 1993-08-06 BR BR9307139A patent/BR9307139A/en not_active Application Discontinuation
- 1993-08-06 EP EP93919900A patent/EP0693910A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994007434A1 (en) | 1994-04-14 |
| JPH09506516A (en) | 1997-06-30 |
| BR9307139A (en) | 1999-03-30 |
| CA2142996A1 (en) | 1994-04-14 |
| AU683223B2 (en) | 1997-11-06 |
| AU4998393A (en) | 1994-04-26 |
| EP0693910A1 (en) | 1996-01-31 |
| EP0693910A4 (en) | 1995-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1328544C (en) | Radiolucent breast implant | |
| EP0521015B1 (en) | Bio-osmotic gel for implant prostheses | |
| DE3872191T2 (en) | CHEST PROSTHESIS WITH SEVERAL CHAMBERS. | |
| Shukovsky et al. | Retinal and optic nerve complications in a high dose irradiation technique of ethmoid sinus and nasal cavity | |
| US8680498B2 (en) | Method of utilizing an implant in a human breast | |
| Sewall et al. | Late reaction to silicone following reconstruction of an orbital floor fracture | |
| CA2513665A1 (en) | Solid implant | |
| Eyssen et al. | Reconstruction of the breast using polyurethane-coated prostheses | |
| Hunter et al. | Medical devices of the head, neck, and spine | |
| Morita et al. | Late effects on the eye of conformation radiotherapy for carcinoma of the paranasal sinuses and nasal cavity | |
| CA2142996C (en) | Breast implant with radiolucent shell | |
| Sealy et al. | Progress in the use of iodine therapy for tumours of the eye | |
| Daniels et al. | CT recognition of optic nerve sheath meningioma: abnormal sheath visualization. | |
| AU5083593A (en) | Penile implant with triglyceride fill | |
| US5653758A (en) | Method of using a radiolucent organ displacement device for radiation therapy | |
| Apesos et al. | Silicone granuloma following closed capsulotomy of mammary prosthesis | |
| Flanders et al. | MRI of orbital hydroxyapatite implants | |
| Van der Meulen et al. | The management of orbitofacial neurofibromatosis | |
| Molteno et al. | " Physiological" orbital implant. | |
| Scanlon | The role of reconstruction in breast cancer | |
| Menzel et al. | Vascularisation of ocular coralline hydroxyapatite implants | |
| Helms et al. | Complications following enucleation and implantation of multiple glass spheres in the orbit | |
| Kumar et al. | Spinal metastases from pituitary hemangiopericytic meningioma | |
| Pradeep Kumar et al. | High‐activity iodine‐125 endocurietherapy for head and neck tumors | |
| Kumar et al. | Reversal of visual impairment after interstitial irradiation of pituitary tumor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20130806 |
|
| MKEC | Expiry (correction) |
Effective date: 20131009 |
|
| MKEC | Expiry (correction) |
Effective date: 20131009 |